RTX Corporation (RTX)

President Donald Trump said on Wednesday that the companies Raytheon Technologies and IBM may get the contract to modernize the nation's air traffic controller system.

RTX (RTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Northrop Grumman and RTX  fell 12.2% and 8.8%, respectively, on April 22 compared to a 1.9% gain for Lockheed Martin (LMT -0.19%).

Investors interested in RTX stock should avoid adding it to their portfolio, considering its premium valuation and downward revision in earnings estimates.

Volatility is flashing a Blue Light Special in markets. Fear is high, but history says these moments often reward long-term investors the most. I see this uncertainty as an opportunity. When panic str...

Defense stocks are pulling back following Q1 reports from Lockheed Martin NYSE: LMT, Northrop Grumman NYSE: NOC, and RTX NYSE: RTX. The primary cause is uncertainty, followed by tepid guidance.

BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa.

RTX Corporation delivered a strong Q1: sales up 5% YoY ($20.3B), EPS rose 10% ($1.47), FCF at $792M; backlog secure at $217B (Commercial: $125B, Defense: $92B), ensuring revenue visibility. Tariffs co...

RTX's Q1 sales grew 8% organically to $20.3 billion, beating analyst expectations with adjusted EPS up 10% to $1.47. Despite strong results, RTX's stock fell 10% due to tariff impacts, with an estimat...

Investors may stay invested in RTX due to balanced exposure across segments. Lockheed could be more appealing to those seeking attractive valuation.